Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

A weight loss program with a special fast helped patients lose an average of 41-47 pounds and improved their health, but maintaining the weight loss was challenging.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Zizyphus jujuba essential oil can promote hair growth.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Scientists found a way to grow human hair cells in a lab that can create new hair when transplanted.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Spironolactone helps regrow hair in women with hair loss.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Some alternative treatments for hair loss might work, but more research is needed.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Minoxidil effectively treats female pattern hair loss.